PARENTERAL A S has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Czechia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are DECIMA HEALTH LTD, SCIODERM INC and UNI PRESIDENT BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Czechia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | China | 1 | |
#5 | Hungary | 1 | |
#6 | Israel | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Horska Irena | 5 |
#2 | Husek Jiri | 3 |
#3 | Skalicky Jiri | 3 |
#4 | Dittrich Milan | 3 |
#5 | Hofbauerova Jana | 2 |
#6 | Horska Irena Mgr | 1 |
#7 | Hofbasrova Jana | 1 |
#8 | Irena Horska | 1 |
#9 | Hofbauerová Jana | 1 |
#10 | Skalicky Jirí | 1 |
Publication | Filing date | Title |
---|---|---|
EP2444081A1 | A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol | |
CZ2011541A3 | Composition for treating inflammatory diseases | |
CZ2010764A3 | Composition for the treatment of inflammatory diseases | |
WO2005058332A2 | Edestin-comprising agent for substitution of blood plasma and a method of its production | |
EP1706127A1 | Penetration enhancing agent and method of its production from the hemp seeds | |
CZ20031188A3 | Cosmetic and therapeutical composition |